nach oben

Clinical Research in Cardiology

Erschienen in:

26.02.2018 | Letter to the Editors

Very late erosion of Amplatzer occluder device resulting in Cardiac tamponade after 15 years

verfasst von: Jan-Erik Guelker, Ruben Jansen, Kolja Sievert, Horst Sievert, Stefan Bertog

Erschienen in: Clinical Research in Cardiology | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Excerpt

Sirs, …

King TD, Thompson SL, Steiner C, Mills NL (1976) Secundum atrial septal defect. Nonoperative closure during cardiac catheterization. JAMA 235:2506–2509CrossRefPubMed

Berger F, Vogel M, Alexi-Meskishvili V, Lange PE (1999) Comparison of results and complications of surgical and Amplatzer device closure of atrial septal defects. J Thorac Cardiovasc Surg 118:674–678CrossRefPubMed

Moore J, Hegde S, El-Said H, Beekman R 3rd, Benson L, Bergersen L, Holzer R, Jenkins K, Ringel R, Rome J, Vincent R, Martin G, for the ACC IMPACT Steering Committee (2013) Transcatheter device closure of atrial septal defects: a safety review. JACC Cardiovasc Interv 6:433–442CrossRefPubMed

U.S. FDA (2012) FDA Executive Summary Memorandum—May 24, 2012: Circulatory system advisory panel meeting—transcatheter ASD occluders: clinical update and review of events [pdf]. http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/CirculatorySystemDevicesPanel/ucm300073.htm. Accessed 24 May 2012

Krumsdorf U, Ostermayer S, Billinger K, Trepels T, Zadan E, Horvath K, Sievert H (2004) Incidence and clinical course of thrombus formation on atrial septal defect and patent foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol 43:302–309CrossRefPubMed

McElhinney DB, Quartermain MD, Kenny D, Alboliras E, Amin Z (2016) Relative risk factors for cardiac erosion following transcatheter closure of atrial septal defects: a case-control study. Circulation 133(18):1738–1746CrossRefPubMed

Amin Z, Hijazi ZM, Bass JL, Cheatham JP, Hellenbrand WE, Kleinman CS (2004) Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv 63(4):496–502CrossRefPubMed

El-Said HG, Moore JW (2009) Erosion by the Amplatzer septal occluder: experienced operator opinions at odds with manufacturer recommendations? Catheter Cardiovasc Interv 73(7):925–930CrossRefPubMed

Baumgartner H, Bonhoeffer P, De Groot NMS et al (2010) ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J 31:2915–2957CrossRefPubMed

10.

Butera G, Carminati M, Chessa M, Youssef R, Drago M, Giamberti A, Pome` G, Bossone E, Frigiola A (2006) Percutaneous versus surgical closure of secundum atrial septal defect: comparison of early results and complications. Am Heart J 151:228–234CrossRefPubMed

11.

Fischer G, Stieh J, Uebing A, Hoffmann U, Morf G, Kramer HH (2003) Experience with transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: a single centre study in 236 consecutive patients. Heart 89:199–204CrossRefPubMedPubMedCentral

12.

Du ZD, Hijazi ZM, Kleinman CS, Silverman NH, Larntz K (2002) Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J Am Coll Cardiol 39:1836–1844CrossRefPubMed

13.

Roberts WT, Parmar J, Rajathurai T (2013) Very late erosion of Amplatzer septal occludedevice presenting as pericardial pain and effusion 8 years after placement. Catheter Cardiovasc Interv 82:E592–E594CrossRefPubMed

14.

Amin Z (2014) Echocardiographic predictors of cardiac erosion after Amplatzer septal occluder placement. Catheter Cardiovasc Interv 83(1):84–92CrossRefPubMed

Titel: Very late erosion of Amplatzer occluder device resulting in Cardiac tamponade after 15 years
verfasst von: Jan-Erik Guelker
Ruben Jansen
Kolja Sievert
Horst Sievert
Stefan Bertog
Publikationsdatum: 26.02.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Clinical Research in Cardiology / Ausgabe 6/2018
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI: https://doi.org/10.1007/s00392-018-1222-6

Neu im Fachgebiet Kardiologie

25.04.2024 | Hypotonie | Nachrichten

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Very late erosion of Amplatzer occluder device resulting in Cardiac tamponade after 15 years

Excerpt

Neu im Fachgebiet Kardiologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adipositas-Medikament auch gegen Schlafapnoe wirksam

Komplette Revaskularisation bei Infarkt: Neue Studie setzt ein Fragezeichen

Update Kardiologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2018

The clinical relevance of drug–drug interaction between co-trimoxazole and sacubitril/valsartan treatment in a heart failure patient: a case report and overview of mechanisms and management in clinical practice

Impact of generalized anxiety disorder (GAD) on prehospital delay of acute myocardial infarction patients. Findings from the multicenter MEDEA study

Patient-specific registration of 3D CT angiography (CTA) with X-ray fluoroscopy for image fusion during transcatheter aortic valve implantation (TAVI) increases performance of the procedure

Arrhythmia-free survival and pulmonary vein reconnection patterns after second-generation cryoballoon and contact-force radiofrequency pulmonary vein isolation

Correction to: Prognostic impact of baseline glucose levels in acute myocardial infarction complicated by cardiogenic shock—a substudy of the IABP-SHOCK II-trial

Risk marker profiles in patients treated with percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy

Neu im Fachgebiet Kardiologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adipositas-Medikament auch gegen Schlafapnoe wirksam

Komplette Revaskularisation bei Infarkt: Neue Studie setzt ein Fragezeichen

Update Kardiologie